1-20 of 23
Sort by
News

More Work Needed to Overcome Racial, Ethnic AHCT Disparities in Multiple Myeloma

Katie Robinson
Published: 2024
Abstract
December 2024
View News titled, More Work Needed to Overcome Racial, Ethnic AHCT Disparities in Multiple Myeloma
News

Discontinuing Maintenance Therapy for Multiple Myeloma Is Feasible, New Study Shows

Anna Azvolinsky, PhD
Published: 2024
Abstract
December 2024
View News titled, Discontinuing Maintenance Therapy for Multiple Myeloma Is Feasible, New Study Shows
News

New Risk Classification Stratifies Outcomes in Older Intensively Treated Patients with AML

Lara C. Pullen, PhD
Published: 2024
Abstract
December 2024
View News titled, New Risk Classification Stratifies Outcomes in Older Intensively Treated Patients with AML
News

Weekly Low-Dose Regimen of Decitabine and Venetoclax as Effective as Higher Dose

Lara C. Pullen, PhD
Published: 2024
Abstract
December 2024
View News titled, Weekly Low-Dose Regimen of Decitabine and Venetoclax as Effective as Higher Dose
News

ASH Recruitment Program Boosts Representation in Hematology Field, Study Shows

Anna Azvolinsky, PhD
Published: 2024
Abstract
December 2024
View News titled, ASH Recruitment Program Boosts Representation in Hematology Field, Study Shows
News

BOVen Regimen NCCN-Approved Option for TP53-Mutated MCL

Leah Lawrence
Published: 2024
Abstract
December 2024
View News titled, BOVen Regimen NCCN-Approved Option for TP53-Mutated MCL
News

ASH Clinical News: A Decade in Review

Published: 2024
Abstract
December 2024
View News titled, ASH Clinical News: A Decade in Review
News

December 2024 Data Stream

Published: 2024
Abstract
December 2024
View News titled, December 2024 Data Stream
News

Significant Proportion of Cancer Trials Exclude Individuals with Duffy Null–Associated Neutrophil Count, Study Finds

Anna Azvolinsky, PhD
Published: 2024
Abstract
December 2024
View News titled, Significant Proportion of Cancer Trials Exclude Individuals with Duffy Null–Associated Neutrophil Count, Study Finds
News

Lactated Ringer Preferred Over Normal Saline in SCD Vaso-Occlusive Episodes

Ruth Jessen Hickman, MD
Published: 2024
Abstract
December 2024
View News titled, Lactated Ringer Preferred Over Normal Saline in SCD Vaso-Occlusive Episodes
News

MGUS Risk Assessment Over Time Yields Benefits, Study Shows

Thomas R. Collins
Published: 2024
Abstract
December 2024
View News titled, MGUS Risk Assessment Over Time Yields Benefits, Study Shows
News

Soluble Anti-B-Cell Maturation Antigen, High Disease Burden Modulate Responses in Patients With MM Receiving BCMA T-Cell–Engager Therapy

Lara C. Pullen, PhD
Published: 2024
Abstract
December 2024
View News titled, Soluble Anti-B-Cell Maturation Antigen, High Disease Burden Modulate Responses in Patients With MM Receiving BCMA T-Cell–Engager Therapy
News

Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Respond Well to Asciminib, Dasatinib

Lara C. Pullen, PhD
Published: 2024
Abstract
December 2024
View News titled, Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Respond Well to Asciminib, Dasatinib
News

ASH Elects Four New Leaders to the Executive Committee

Published: 2024
Abstract
December 2024
View News titled, ASH Elects Four New Leaders to the Executive Committee
News

Judith Kleinerman Receives ASH Exemplary Service Award

Published: 2024
Abstract
December 2024
View News titled, Judith Kleinerman Receives ASH Exemplary Service Award
News

Toxic Exposure: Into the Weeds of the Monsanto Trials

Naseema Gangat, MBBS
Published: 2024
Abstract
December 2024 In this edition, Naseema Gangat, MBBS, reviews Toxic Exposure: The True Story Behind the Monsanto Trials and the Search for Justice by Chadi Nabhan, MD, MBA.
View News titled, Toxic Exposure: Into the Weeds of the Monsanto Trials
News

Pulling Back the Curtain: Belinda R. Avalos, MD

Jill Sederstrom
Published: 2024
Abstract
December 2024 In this edition,  Belinda R. Avalos, MD,  the 2024 American Society of Hematology (ASH) president-elect, talks about her career inspirations, research accomplishments, and passion for improving diversity, equity, and inclusion in the field of hematology.
View News titled, Pulling Back the Curtain: Belinda R. Avalos, MD
News

How would you treat progressive classical Hodgkin lymphoma in a patient who has received multiple lines of therapy?

Published: 2024
Abstract
December 2024
View News titled, How would you treat progressive classical Hodgkin lymphoma in a patient who has received multiple lines of therapy?
News

Drawing First Blood: How Long Should Patients With a Myeloproliferative Neoplasm Be Anticoagulated?

Leah Lawrence
Published: 2024
Abstract
December 2024
View News titled, Drawing First Blood: How Long Should Patients With a Myeloproliferative Neoplasm Be Anticoagulated?
News

You Make the Call: How would you treat progressive classical Hodgkin lymphoma after multiple lines of therapy?

Published: 2024
Abstract
December 2024
View News titled, You Make the Call: How would you treat progressive classical Hodgkin lymphoma after multiple lines of therapy?